Nautilus Biotechnology, Inc.
NAUT
$0.701
$0.03284.91%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.51% | 5.58% | -6.98% | 8.68% | 3.84% |
| Total Depreciation and Amortization | 0.49% | 4.64% | -3.66% | 0.94% | 0.38% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -21.94% | -51.29% | 35.72% | -4.50% | 9.06% |
| Change in Net Operating Assets | -111.81% | 64.18% | -117.30% | 54.35% | -8.79% |
| Cash from Operations | 4.21% | 2.60% | -9.12% | 15.16% | 4.97% |
| Capital Expenditure | -80.82% | 78.40% | -43.02% | -38.48% | 20.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -24.63% | -48.24% | 661.08% | -145.89% | -35.63% |
| Cash from Investing | -25.82% | -47.42% | 594.55% | -152.49% | -36.05% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 427.78% | -95.91% | 214.29% | -56.11% | 30.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 427.78% | -95.91% | 214.29% | -56.11% | 30.20% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -78.20% | -75.93% | 213.48% | -2,326.07% | -113.33% |